Press Releases
Pfizer says Two additional late stage studies of cholesterol...
Pfizer Inc. announced two additional Phase 3 bococizumab trials, SPIRE-HR and SPIRE-FH , met their primary endpoint, demonstrating a significant reduction in the percent change...
Press Releases
EU approves Astrazeneca Plc’s New Antibiotic Zavicefta
AstraZeneca announced that the EC has granted marketing authorisation for Zavicefta , a new combination antibiotic for the treatment of patients with serious Gram-negative bacterial...
Press Releases
FDA accepted Teva’s Fluticasone Propionate and Fluticasone Propionate RespiClick...
Teva Pharmaceutical Industries Ltd. announced that the U.S. FDA has accepted for review the company’s new drug applications (NDAs) for two products for adolescent and...
Press Releases
Novo Nordisk receives the EMA marketing approval of the...
Novo Nordisk announces the EMA marketing approval of the mylife(TM) YpsoPump® insulin pump for use with prefilled pump cartridge NovoRapid®PumpCart®. The approval is a key...
Press Releases
Teva and Antares Pharma Announce Launch of Generic Imitrex...
Teva Pharmaceutical Industries Ltd. and Antares Pharma, Inc. announced the launch of the generic equivalent to Imitrex injection, 4 mg and 6 mg single-dose, prefilled...
Press Releases
Teva and Antares Pharma Announce Launch of Generic Imitrex...
Teva Pharmaceutical Industries Ltd and Antares Pharma, Inc. announced the launch of the generic equivalent to Imitrex®1 (sumatriptan succinate) injection, 4 mg and 6 mg...
Press Releases
Teva Pharmaceutical Receives Positive CHMP Opinion on CINQAERO
Teva Pharmaceutical Industries Ltd announced that the EMA Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending marketing authorization for...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.